# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-058699
Filing Date
2025-04-25
Accepted
2025-04-25 16:05:15
Documents
18
Period of Report
2025-06-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | iobt-20250424.htm iXBRL | DEF 14A | 778374
2 | GRAPHIC | img135870972_0.jpg | GRAPHIC | 85197
3 | GRAPHIC | img135870972_1.jpg | GRAPHIC | 17280
4 | GRAPHIC | img135870972_2.jpg | GRAPHIC | 46564
5 | GRAPHIC | img135870972_3.jpg | GRAPHIC | 17280
6 | GRAPHIC | img135870972_4.jpg | GRAPHIC | 391357
7 | GRAPHIC | img135870972_5.jpg | GRAPHIC | 334338
| Complete submission text file | 0000950170-25-058699.txt |  | 2976691

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | iobt-20250424.xsd | EX-101.SCH | 7930
20 | EXTRACTED XBRL INSTANCE DOCUMENT | iobt-20250424_htm.xml | XML | 7472

Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41008 | Film No.: 25873793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)